• Protalix (NYSE: $PLX) is dedicated to developing and commercializing therapeutic proteins with clinically improved profiles, produced by our ProCellEx® system.
  • Protalix (NYSE: $PLX) is dedicated to developing and commercializing therapeutic proteins with clinically improved profiles, produced by our ProCellEx® system.
  • Protalix new Corporate Presentation not put the exact milestone numbers from Chiesi but should be not less than $50M (For 2Q'25 with 0 Debt and 0 cash).
  • Protalix regnskab var lidt for spændende. http://inrater.com/protalix-regnskab-var-lidt-spaendende/…
  • Protalix BioTherapeutics and Chiese Global Rare Diseases Report Topline Results from the Phase III BALANCE Clinical Trial #ClinicalTrials $PLX #ProtalixBioTherapeutics...